Table 3.
In vitro antimicrobial susceptibility pattern of the bacteria isolates.
| Antibiotics | Pattern (S or R) | Citrobacter spp. (n = 15) | Citrobacter freundii (n = 10) | Staphylococcus aureus (n = 5) | Staphylococcus hominis (n = 1) |
|---|---|---|---|---|---|
| Gentamicin | S | 13 (86.7) | 8 (80) | 4 (80) | 1 (100) |
| R | 2 (13.3) | 2 (20) | 1 (20) | 0 (0) | |
| Ciprofloxacin | S | 12 (80.0) | 9 (90) | 5 (100) | 1 (100) |
| R | 3 (20.0) | 1 (10) | 0 (0) | 0 (0) | |
| Levofloxacin | S | 13 (86.7) | 8 (80) | 4 (80) | 1 (100) |
| R | 2 (13.3) | 2 (20) | 1 (20) | 0 (0) | |
| Ampicillin | S | 1 (6.7) | 2 (20) | 1 (20) | 0 (0) |
| R | 14 (93.3) | 8 (80) | 4 (80) | 1 (100) | |
| Cefuroxime | S | 3 (20.0) | 3 (30) | 1 (20) | 1 (100) |
| R | 12 (80.0) | 7 (70) | 4 (80) | 0 (0) | |
| Tetracycline | S | 14 (93.3) | 2 (20) | 0 (0) | 1 (100) |
| R | 1 (6.7) | 8 (80) | 5 (100) | 0 (0) | |
| Amoxicillin/Clavulanic acid | S | 14 (93.3) | 9 (90) | 4 (80) | 1 (100) |
| R | 1 (6.7) | 1 (10) | 1 (20) | 0 (0) | |
| Ceftriaxone | S | 3 (20.0) | 2 (20) | 5 (100) | 1 (100) |
| R | 12 (80.0) | 8 (80) | 0 (0) | 0 (0) | |
| Penicillin | S | NT | NT | 0 (0) | 0 (0) |
| R | 5 (100) | 1 (100) | |||
| Linezolid | S | NT | NT | 5 (100) | 1 (100) |
| R | 0 (0) | 0 (0) | |||
| Teicoplanin | S | NT | NT | 5 (100) | 1 (100) |
| R | 0 (0) | 0 (0) | |||
| Erythromycin | S | NT | NT | 1 (20) | 1 (100) |
| R | 4 (80) | 0 (0) |
NT: not tested, S: susceptible, R: resistant.